Helping emergency doctors make faster decisions with AI

Using Australian-developed artificial intelligence to improve emergency care.

Helping emergency doctors make faster decisions with AI

Using Australian-developed artificial intelligence to improve emergency care.
Read Transcript

The challenge

Emergency departments are under increasing pressure, with overcrowding becoming one of the biggest challenges facing the NSW health system. Doctors and nurses often need to make complex decisions about the most appropriate care for each patient, all while working under significant time pressure. Better tools to support these decisions could help patients receive the right care sooner, while improving patient flow and easing pressure on busy emergency departments.

The research

Researchers at the RPA Green Light Institute have developed The Sydney Triage to Admission Risk Tool with Artificial Intelligence (START-AI), a world-first Australian artificial intelligence tool designed to help clinicians predict whether a patient is likely to require hospital admission or can be safely discharged. Building on more than a decade of research, START-AI combines advanced artificial intelligence with clinician expertise to analyse routinely collected health information and provide real-time decision support at the bedside. 

Rather than replacing clinical judgement, START-AI is designed to support clinicians by providing additional information to help them make faster, more informed decisions. The research team is now working with NSW Health, emergency departments across metropolitan and regional NSW, and digital health leaders to implement and evaluate START-AI in real-world clinical settings.

The role of philanthropy

Funding from Hearts & Minds has helped strengthen the research capability, innovation infrastructure and collaborative partnerships needed to develop and evaluate innovative approaches to emergency care. This support has enabled the RPA Green Light Institute to generate the evidence, research publications and translational expertise required to advance START-AI from an innovative research concept towards real-world implementation across the NSW health system.


Looking ahead

The original Sydney Triage to Admission Risk Tool has already been integrated into NSW Health's Patient Flow Portal, demonstrating how Australian research can be successfully translated into everyday clinical practice. By building on this foundation, START-AI has the potential to improve the accuracy of admission decisions, reduce emergency department delays and help more patients receive timely, appropriate care.


If successfully implemented, the project could establish NSW as a global leader in AI-enabled emergency care while creating a framework for the safe introduction of artificial intelligence into public hospitals, improving care for thousands of patients each year.

Funding support from Hearts & Minds, as nominated by Regal Funds Management. This content was last updated in July 2026. For further information, visit RPA Green Light Institute for Emergency Care.

The challenge

Emergency departments are under increasing pressure, with overcrowding becoming one of the biggest challenges facing the NSW health system. Doctors and nurses often need to make complex decisions about the most appropriate care for each patient, all while working under significant time pressure. Better tools to support these decisions could help patients receive the right care sooner, while improving patient flow and easing pressure on busy emergency departments.

The research

Researchers at the RPA Green Light Institute have developed The Sydney Triage to Admission Risk Tool with Artificial Intelligence (START-AI), a world-first Australian artificial intelligence tool designed to help clinicians predict whether a patient is likely to require hospital admission or can be safely discharged. Building on more than a decade of research, START-AI combines advanced artificial intelligence with clinician expertise to analyse routinely collected health information and provide real-time decision support at the bedside. 

Rather than replacing clinical judgement, START-AI is designed to support clinicians by providing additional information to help them make faster, more informed decisions. The research team is now working with NSW Health, emergency departments across metropolitan and regional NSW, and digital health leaders to implement and evaluate START-AI in real-world clinical settings.

The role of philanthropy

Funding from Hearts & Minds has helped strengthen the research capability, innovation infrastructure and collaborative partnerships needed to develop and evaluate innovative approaches to emergency care. This support has enabled the RPA Green Light Institute to generate the evidence, research publications and translational expertise required to advance START-AI from an innovative research concept towards real-world implementation across the NSW health system.


Looking ahead

The original Sydney Triage to Admission Risk Tool has already been integrated into NSW Health's Patient Flow Portal, demonstrating how Australian research can be successfully translated into everyday clinical practice. By building on this foundation, START-AI has the potential to improve the accuracy of admission decisions, reduce emergency department delays and help more patients receive timely, appropriate care.


If successfully implemented, the project could establish NSW as a global leader in AI-enabled emergency care while creating a framework for the safe introduction of artificial intelligence into public hospitals, improving care for thousands of patients each year.

Funding support from Hearts & Minds, as nominated by Regal Funds Management. This content was last updated in July 2026. For further information, visit RPA Green Light Institute for Emergency Care.

Disclaimer: This material has been prepared by Hearts & Minds, published on . HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
July 1, 2026

Improving care for adults with motor neuron diseases

Building better care for adults living with Motor Neuron Disease and Spinal Muscular Atrophy.

Read More
July 1, 2026

Understanding fatigue in young people with Charcot-Marie-Tooth disease

Developing a tool to improve understanding, research and care.

Read More
Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).
July 1, 2026

Giving families living with rare diseases the answers they need

Supporting research to improve the diagnosis of rare genetic neuromuscular diseases and build the foundations for future treatments.

Read More
Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher
July 1, 2026

Understanding spinal cord injury recovery

The world's first molecular map of spinal cord injury across time and injury levels

Read More
Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium
July 1, 2026

Building the foundations for faster progress against brain cancer

Uniting researchers, clinicians and patients to accelerate research and improve patient care.

Read More
July 1, 2026

Accelerating CAR-T cell therapies for patients in need 

Bringing innovative cancer therapies closer to patients.

Read More
July 1, 2026

Supporting babies at high risk of cerebral palsy from the very beginning

Testing a family-centred early intervention program to improve outcomes for infants and support parents during the first critical months of life.

Read More
July 1, 2026

Making early cerebral palsy screening more accessible

Exploring new ways to identify babies at risk of cerebral palsy sooner and support better outcomes.

Read More
Picture: Professor Tracy Putoczki, Laboratory Head at WEHIPicture: Professor Tracy Putoczki, Laboratory Head at WEHIPicture: Professor Tracy Putoczki, Laboratory Head at WEHIPicture: Professor Tracy Putoczki, Laboratory Head at WEHI
July 1, 2026

Mapping the surface of pancreatic cancer cells

Identifying proteins on pancreatic cancer cells that could become new targets for developing future treatments.

Read More
Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI
July 1, 2026

Understanding how breast cancer begins

Tracking the earliest changes in BRCA mutation carriers to help prevent cancer before it starts.

Read More
July 1, 2026

A new path forward for women living with period and pelvic pain

Uncovering the biology driving debilitating symptoms

Read More
Picture: Professor Daniel MacArthurPicture: Professor Daniel MacArthurPicture: Professor Daniel MacArthurPicture: Professor Daniel MacArthur
July 1, 2026

Closing the gap in rare disease diagnosis for Australian families

Building better genomic tools and more representative data to help families receive answers sooner.

Read More
PICTURE: A/Prof Rebecca Nisbet and her teamPICTURE: A/Prof Rebecca Nisbet and her teamPICTURE: A/Prof Rebecca Nisbet and her teamPICTURE: A/Prof Rebecca Nisbet and her team
July 1, 2026

Developing a new mRNA vaccine for Alzheimer’s disease

Using innovative technology to explore new possibilities for treatment and prevention.

Read More
Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS. Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS. Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS. Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS.
July 1, 2026

Unlocking new approaches for Multiple Sclerosis

Understanding why the brain fails to repair itself and exploring new treatment possibilities.

Read More
December 5, 2023

Prof Daniel MacArthur | 2023 Sohn Hearts & Minds Conference

At the 2023 Sohn Hearts & Minds Conference, we heard from Prof Daniel MacArthur, the Director of the Centre for Population Genomics.

Read More